SEARCH
Quotes News NAV
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
ERIS Lifesciences Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540596 INE406M01024 203.3941378 ERIS 0.47 21,399.67 75.93 20.69 1
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.960.610.080.000.00
Long Term Debt-Equity Ratio0.430.150.050.000.00
Current Ratio0.961.152.542.862.73
Fixed Assets0.731.051.431.631.57
Inventory12.0519.6818.0516.2517.02
Debtors7.166.517.319.678.71
Interest Cover Ratio1.556.7322.00151.34414.72
PBIDTM (%)30.6431.9738.9742.2038.55
PBITM (%)19.9725.2734.1537.9735.16
PBDTM (%)17.7128.2237.4241.9538.47
CPM (%)15.2126.3134.5238.5535.01
APATM (%)4.5419.6129.6934.3231.62
ROCE (%)6.839.9719.9425.6826.48
RONW (%)3.0712.6319.2323.8824.39